A肉毒毒素注射概要課件

1、not fda approved for this usecarruthers j, carruthers a. dermatol clin. 2004;22:151-158.depresso anguli orisnot fda approved for this usebonta=botulinum toxin type anot fda approved for this usenot fda approved for this useplatysma pars facialiscarruthers j, carruthers a. dermatol clin. 2004;22:151-

2、158.insert figure 5 f from carruthers. dermatol surg. 2003.not fda approved for this usenot fda approved for this usenot fda approved for this usethe american society for aesthetic plastic surgery. cosmetic surgery national data bank 2006 statistics.available at: /press/statisti

3、cs-2006.php. accessed march 19, 2007.bonta=botulinum toxin type abonta=botulinum toxin type anot fda approved for this usenot fda approved for this usebonta=botulinum toxin type a; nasha=non animal-stabilized hyaluronic acidbaselinenot fda approved for this usenot fda approved for this usenot fda ap

4、proved for this usebonta=botulinum toxin type aphoto courtesy of nowell solish, md.not fda approved for this usesurgery: local sweat gland resectionhornberger j et al. j am acad dermatol. 2004;51:274-286.not fda approved for this usesommer b, sattler g, eds. botulinum toxin in aesthetic medicine. bo

5、ston, mass: blackwell science; 2001.depressor labii inf.bonta=botulinum toxin type a.not fda approved for this usenot fda approved for this usenot fda approved for this usenot fda approved for this usenot fda approved for this usenot fda approved for this usenot fda approved for this usenot fda appr

6、oved for this usenot fda approved for this use-0.28 weeks-0.8medialmidpupillateraln=20medialmidpupillateral0.6-0.212 weeks*millimeters4 weeks20 weeksmedialmidpupillateral0.20.61*p0.05; n=20medialmidpupillateral*16 weeks2 weeks0.4-0.4carruthers a, carruthers c. dermatol surg. 2007;33(suppl 1):s26-s31.804075 u0placebop0.001 vs placebo65/